nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC6A2—autonomic nervous system—rectum cancer	0.0907	0.115	CbGeAlD
Amphetamine—CARTPT—female reproductive system—rectum cancer	0.0698	0.0882	CbGeAlD
Amphetamine—TAAR1—female reproductive system—rectum cancer	0.0698	0.0882	CbGeAlD
Amphetamine—CARTPT—lymph node—rectum cancer	0.0409	0.0516	CbGeAlD
Amphetamine—SLC18A2—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0341	0.164	CbGpPWpGaD
Amphetamine—CYP2A6—seminal vesicle—rectum cancer	0.0328	0.0415	CbGeAlD
Amphetamine—SLC22A3—seminal vesicle—rectum cancer	0.0262	0.0331	CbGeAlD
Amphetamine—MAOB—seminal vesicle—rectum cancer	0.0242	0.0306	CbGeAlD
Amphetamine—SLC18A2—female reproductive system—rectum cancer	0.0237	0.03	CbGeAlD
Amphetamine—SLC6A2—Amine compound SLC transporters—SLC14A2—rectum cancer	0.023	0.11	CbGpPWpGaD
Amphetamine—SLC22A3—smooth muscle tissue—rectum cancer	0.0219	0.0277	CbGeAlD
Amphetamine—SLC18A2—vagina—rectum cancer	0.0215	0.0271	CbGeAlD
Amphetamine—SLC22A3—renal system—rectum cancer	0.0211	0.0267	CbGeAlD
Amphetamine—SLC22A3—urethra—rectum cancer	0.0207	0.0262	CbGeAlD
Amphetamine—SLC6A3—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0203	0.0975	CbGpPWpGaD
Amphetamine—SLC22A3—mammalian vulva—rectum cancer	0.0197	0.0249	CbGeAlD
Amphetamine—MAOB—renal system—rectum cancer	0.0195	0.0247	CbGeAlD
Amphetamine—MAOB—urethra—rectum cancer	0.0192	0.0242	CbGeAlD
Amphetamine—CYP2A6—vagina—rectum cancer	0.0192	0.0242	CbGeAlD
Amphetamine—SLC22A5—seminal vesicle—rectum cancer	0.019	0.0241	CbGeAlD
Amphetamine—MAOB—mammalian vulva—rectum cancer	0.0183	0.0231	CbGeAlD
Amphetamine—SLC22A3—female reproductive system—rectum cancer	0.0169	0.0214	CbGeAlD
Amphetamine—SLC6A4—female reproductive system—rectum cancer	0.0164	0.0208	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—TYMS—rectum cancer	0.0159	0.0761	CbGpPWpGaD
Amphetamine—MAOB—female reproductive system—rectum cancer	0.0156	0.0198	CbGeAlD
Amphetamine—SLC22A5—renal system—rectum cancer	0.0153	0.0194	CbGeAlD
Amphetamine—SLC22A3—vagina—rectum cancer	0.0153	0.0193	CbGeAlD
Amphetamine—SLC22A5—urethra—rectum cancer	0.0151	0.019	CbGeAlD
Amphetamine—SLC6A2—female reproductive system—rectum cancer	0.0145	0.0183	CbGeAlD
Amphetamine—MAOB—vagina—rectum cancer	0.0141	0.0179	CbGeAlD
Amphetamine—SLC18A2—lymph node—rectum cancer	0.0139	0.0175	CbGeAlD
Amphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0133	0.064	CbGpPWpGaD
Amphetamine—SLC22A5—female reproductive system—rectum cancer	0.0123	0.0155	CbGeAlD
Amphetamine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0115	0.0553	CbGpPWpGaD
Amphetamine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0115	0.0551	CbGpPWpGaD
Amphetamine—SLC22A5—vagina—rectum cancer	0.0111	0.014	CbGeAlD
Amphetamine—CYP2D6—renal system—rectum cancer	0.0099	0.0125	CbGeAlD
Amphetamine—SLC22A3—lymph node—rectum cancer	0.00989	0.0125	CbGeAlD
Amphetamine—MAOB—lymph node—rectum cancer	0.00915	0.0116	CbGeAlD
Amphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.00898	0.043	CbGpPWpGaD
Amphetamine—SLC6A2—lymph node—rectum cancer	0.00847	0.0107	CbGeAlD
Amphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.00796	0.0381	CbGpPWpGaD
Amphetamine—CYP2D6—female reproductive system—rectum cancer	0.00793	0.01	CbGeAlD
Amphetamine—SLC22A5—lymph node—rectum cancer	0.00719	0.00908	CbGeAlD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00606	0.0291	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.00538	0.0258	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—TP53—rectum cancer	0.00527	0.0252	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00524	0.0251	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00523	0.0251	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00431	0.0207	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00408	0.0196	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00362	0.0173	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00308	0.0148	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00267	0.0128	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00266	0.0127	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00207	0.00994	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00184	0.0088	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TYMS—rectum cancer	0.0016	0.00765	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—TP53—rectum cancer	0.00143	0.00685	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TYMS—rectum cancer	0.000976	0.00468	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—rectum cancer	0.00065	0.00311	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—rectum cancer	0.000529	0.00254	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—NRAS—rectum cancer	0.000498	0.00239	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—HRAS—rectum cancer	0.000498	0.00239	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—KRAS—rectum cancer	0.000428	0.00205	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—TYMS—rectum cancer	0.000404	0.00194	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000387	0.00186	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRAS—rectum cancer	0.000364	0.00175	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TYMS—rectum cancer	0.000342	0.00164	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—rectum cancer	0.000324	0.00155	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—HRAS—rectum cancer	0.000297	0.00142	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NRAS—rectum cancer	0.000294	0.00141	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—rectum cancer	0.000253	0.00121	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—rectum cancer	0.000225	0.00108	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—rectum cancer	0.000215	0.00103	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TYMS—rectum cancer	0.000197	0.000943	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NRAS—rectum cancer	0.000116	0.000556	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TYMS—rectum cancer	0.00011	0.000529	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—rectum cancer	9.99e-05	0.000479	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—rectum cancer	8.49e-05	0.000407	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NRAS—rectum cancer	6.86e-05	0.000329	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—rectum cancer	5.9e-05	0.000283	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—rectum cancer	5.25e-05	0.000251	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—rectum cancer	5.02e-05	0.00024	CbGpPWpGaD
